Amelia Mackenzie is a Scientist in Global Health, Population and Nutrition at FHI 360. Her research studies user preferences and other social-behavioral factors impacting perceptions of novel contraceptive methods in the development pipeline. She has a particular interest in the impact of contraceptive methods on the menstrual cycle, as well as wider intersections between menstrual health and sexual and reproductive health and rights.
Before joining FHI 360, Mackenzie worked at the Johns Hopkins Bloomberg School of Public Health on the Performance Monitoring and Accountability 2020 (PMA2020) project monitoring contraceptive use and access via household and health facility surveys in countries across Africa and Asia. Her experience in the field of reproduction also extends to the laboratory, where her research has examined the origin of various types of poor reproductive outcomes by identifying molecular and mechanical abnormalities in oocytes that develop after ovulation and a clinical treatment for advanced maternal age infertility.
Mackenzie has a PhD from the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill and a Master of Science degree in Reproductive Biology from the Johns Hopkins Bloomberg School of Public Health.